Credit Suisse’s Ingevity NGVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $11.2M | Sell |
235,418
-8,075
| -3% | -$363K | 0.01% | 870 |
|
|
2023
Q4 | $11.5M | Sell |
243,493
-57,968
| -19% | -$2.41M | 0.01% | 868 |
|
|
2023
Q3 | $14.4M | Sell |
301,461
-46,532
| -13% | -$2.54M | 0.01% | 749 |
|
|
2023
Q2 | $20.2M | Sell |
347,993
-6,418
| -2% | -$385K | 0.02% | 668 |
|
|
2023
Q1 | $25.3M | Sell |
354,411
-30,033
| -8% | -$2.38M | 0.03% | 599 |
|
|
2022
Q4 | $27.1M | Sell |
384,444
-5,024
| -1% | -$354K | 0.03% | 580 |
|
|
2022
Q3 | $23.6M | Sell |
389,468
-26,520
| -6% | -$1.78M | 0.03% | 612 |
|
|
2022
Q2 | $26.3M | Sell |
415,988
-44,818
| -10% | -$2.92M | 0.03% | 597 |
|
|
2022
Q1 | $29.5M | Buy |
460,806
+20,217
| +5% | +$1.35M | 0.03% | 626 |
|
|
2021
Q4 | $31.6M | Buy |
440,589
+403,289
| +1,081% | +$30.7M | 0.02% | 856 |
|
|
2021
Q3 | $2.66M | Buy |
37,300
+2,851
| +8% | +$225K | ﹤0.01% | 2593 |
|
|
2021
Q2 | $2.75M | Sell |
34,449
-3,653
| -10% | -$294K | ﹤0.01% | 2595 |
|
|
2021
Q1 | $2.88M | Sell |
38,102
-19,483
| -34% | -$1.42M | ﹤0.01% | 2549 |
|
|
2020
Q4 | $4.36M | Buy |
57,585
+22,440
| +64% | +$1.46M | ﹤0.01% | 2197 |
|
|
2020
Q3 | $1.74M | Sell |
35,145
-3,224
| -8% | -$182K | ﹤0.01% | 2518 |
|
|
2020
Q2 | $2.02M | Buy |
38,369
+6,859
| +22% | +$326K | ﹤0.01% | 2378 |
|
|
2020
Q1 | $1.11M | Sell |
31,510
-27,073
| -46% | -$1.58M | ﹤0.01% | 2578 |
|
|
2019
Q4 | $5.12M | Buy |
58,583
+9,233
| +19% | +$807K | ﹤0.01% | 1861 |
|
|
2019
Q3 | $4.19M | Sell |
49,350
-7,124
| -13% | -$635K | ﹤0.01% | 1896 |
|
|
2019
Q2 | $5.94M | Sell |
56,474
-353
| -0.6% | -$35.5K | 0.01% | 1638 |
|
|
2019
Q1 | $6M | Buy |
56,827
+7,313
| +15% | +$735K | 0.01% | 1582 |
|
|
2018
Q4 | $4.14M | Buy |
49,514
+2,310
| +5% | +$209K | ﹤0.01% | 1713 |
|
|
2018
Q3 | $4.81M | Sell |
47,204
-13,103
| -22% | -$1.26M | ﹤0.01% | 1715 |
|
|
2018
Q2 | $4.88M | Buy |
60,307
+11,540
| +24% | +$917K | ﹤0.01% | 1753 |
|
|
2018
Q1 | $3.59M | Sell |
48,767
-2,741
| -5% | -$205K | ﹤0.01% | 1943 |
|
|
2017
Q4 | $3.63M | Sell |
51,508
-4,756
| -8% | -$343K | ﹤0.01% | 1997 |
|
|
2017
Q3 | $3.51M | Buy |
56,264
+28,726
| +104% | +$1.7M | ﹤0.01% | 2059 |
|
|
2017
Q2 | $1.58M | Sell |
27,538
-16,712
| -38% | -$983K | ﹤0.01% | 2387 |
|
|
2017
Q1 | $2.69M | Sell |
44,250
-10,451
| -19% | -$591K | ﹤0.01% | 2128 |
|
|
2016
Q4 | $3M | Buy |
54,701
+13,333
| +32% | +$639K | ﹤0.01% | 2098 |
|
|
2016
Q3 | $1.91M | Buy |
41,368
+6,900
| +20% | +$291K | ﹤0.01% | 2412 |
|
|
2016
Q2 | $1.17M | Buy |
+34,468
| New | +$1.08M | ﹤0.01% | 2786 |
|
Other funds holding NGVT
ICP
SBH
Credit Suisse's NGVT Position: Q1 2024 in Review
Credit Suisse reduced its Ingevity (NGVT) stake by 3.3% in Q1 2024, selling an estimated $363K and leaving 235,418 shares worth $11.2M. The position accounts for 0.01% of the portfolio, ranked #870.
Credit Suisse first reported a position in NGVT in Q2 2016 and has held it in 32 quarters since. The position peaked at $31.6M in Q4 2021. 259 funds tracked by Wall St. Rank hold NGVT as of Q1 2024.
- Credit Suisse held 235,418 shares of Ingevity worth $11.2M as of Q1 2024.
- Credit Suisse sold 8,075 Ingevity shares in Q1 2024, an estimated $363K.
- Ingevity made up 0.01% of Credit Suisse's portfolio in Q1 2024, its #870 holding.
- Credit Suisse first reported a position in Ingevity in Q2 2016 and has held it in 32 quarters since.
- Credit Suisse's Ingevity position peaked at $31.6M in Q4 2021.
- 259 funds tracked by Wall St. Rank held Ingevity as of Q1 2024.
Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.